On Sunday May 12, 2013, the Institute for Evidence Based Cryonics will organize a symposium about the resuscitation and reintegration of cryonics patients in Portland, Oregon. This is the first public meeting exclusively concerned with the repair, resuscitation, and reintegration of cryonics patients. Alcor President Max More will be one of the speakers at the event.
The symposium is being held at The Cleaners at Ace Hotel (The Cleaners at Ace Hotel
403 SW 10TH AVE, 97205) in downtown Portland, Oregon from 10:00 am to 07:00 pm.
Admission is free. Registration for the event is possible at the event Facebook page.
On Saturday evening, the day prior to the symposium, Aubrey de Grey and Max More will be speaking about rejuvenation biotechnologies and cryonics at the Paragon Restaurant & Bar in Portland, Oregon.
Admission for this event is free and registration for this event is possible on the event Facebook page, too.
The current line-up of speakers is as follows (the exact schedule will be announced soon):
BEN BEST – EFFECTS OF TEMPERATURE ON PRESERVATION AND RESTORATION OF CRYONICS PATIENTS
Macromolecular temperature is a quantification of atomic-level molecular motion. The ability to maintain and reconstruct cryonics patients could be critically dependent on low temperature atomic/molecular motion and on the ability to operate nanomachines at cryogenic temperatures. Possible problems and solutions will be discussed.
Bio: Ben Best was President of the Cryonics Society of Canada for about a decade, after which he was President of the Cryonics Institute for nearly a decade. He is currently Director of Research Oversight for the Life Extension Foundation. The cryonics section of his website is one of the best sources of information about the science behind cryonics available on the internet ( www.benbest.com/cryonics/
CHANA DE WOLF – RECONSTRUCTIVE CONNECTOMICS
Complete preservation of the “connectome” should be sufficient for meaningful resuscitation attempts of cryonics patients but it may not be necessary. As long as the original connectome can be inferred from what is preserved, damage associated with cerebral ischemia or suboptimal cryonics technologies do not necessarily exclude future resuscitation. In this presentation I will present a general framework for reconstructive connectomics and explore theoretical and experimental research directions for reconstructing damaged and altered connectomes.
Bio: Chana de Wolf lives in Portland, Oregon, where she works as a business manager and biomedical researcher. She holds a B.S. in Experimental Psychology (2001), an M.S. in Cognition and Neuroscience (2003), and has extensive management and laboratory experience. She has several years of experience working as a research assistant in a variety of laboratory environments, and has taught college-level courses in neuroscience lab methods and biology. She is a Director and researcher for Advanced Neural Biosciences. Chana joined as a member of the Alcor Life Extension Foundation in 2007 where she also worked as a Research Associate at Alcor to help build a sustainable, multi-faceted cryonics research program
RANDAL KOENE – BRAIN EMULATION AND NEUROPROSTHETICS: A SYSTEM OF FUNCTIONS TO BE SUSTAINED
Being, now or following revival from cryopreservation, ultimately depends on one’s ability to experience and to do so in the manner that is characteristic of one’s individual mind. Recently, it has become possible to address this problem in a concrete and systematic manner, largely due to rapid advances in computational neuroscience and data acquisition, both structurally (the popular field of “connectomics”) and functionally (brain activity mapping). The process of personal experience – like any process – involves some mechanisms operating at a given time under the influence of an environment state, a state that can include sensory input and functional “memory” established as a result of prior conditions. An emulation or prosthesis is then the attempt to replace a system of processing with an equivalent set of mechanisms that carry out the same processing within established success criteria. The engineering approach to understanding a system sufficiently that it can be emulated or replaced by prostheses is known as system identification. I will describe how system identification may be feasibly carried out for an individual human brain, and how constraints and requirements can be learned through projects with iterative improvements. I will present the projects that are underway to develop neuroscience tools with which successful system identification may be accomplished.
Bio: Dr. Randal A. Koene is CEO and Founder of the not-for-profit science foundation Carboncopies.org as well as the neural interfaces company NeuraLink Co. Dr. Koene is Science Director of the 2045 Initiative and a scientific board member in several neurotechnology companies and organizations.
MAX MORE – MAXIMIZING REVIVAL PROBABILITY: PRESERVATION, RECORDING, INTERPOLATION, AND RECONSTRUCTION
The proper ultimate goal of cryonics is reversible suspended animation. While we should continually strive for that goal, we do not know if or when it will be fully achieved. Until then, we must grapple with the probability that cryopreservation will in itself not fully preserve personal identity critical information. A revived individual may be missing pieces of his or her life, or some of the existing pieces may be fuzzier than they were before clinical death. It may be feasible to fill in the gaps and to sharpen the focus by feeding into the repair and revival process biographical information with a high degree of resolution. That information may also serve to validate the accuracy of a reconstructed connectome. Up to the present, cryonics organizations have offered minimal storage of personal-identity relevant information. In this talk, I will consider ways in which members of cryonics organizations could use the emerging tools and technologies associated with the “Quantified Self” concept to capture and record detailed biographical information, and how cryonics organizations could assist with this and convey the resulting data to a future capable of repairing and resuscitating cryonics patients.
Bio: Max More is the President & Chief Executive Officer of the Alcor Life Extension Foundation. More has a degree in Philosophy, Politics, and Economics from St. Anne’s College, Oxford University (1984-87). He was awarded a Dean’s Fellowship in Philosophy in 1987 by the University of Southern California. He studied and taught philosophy at USC with an emphasis on philosophy of mind, ethics, and personal identity, completing his Ph.D. in 1995, with a dissertation that examined issues including the nature of death, and what it is about each individual that continues despite great change over time.
KEEGAN MACINTOSH – REINTEGRATION OF CRYONICS PATIENTS: LEGAL AND LOGISTICAL CONSIDERATIONS
Given the host of complicated problems to be solved before resuscitation of cryonics patients is possible, it is easy to leave planning for their reintegration for another day. However, this assumes that there is nothing particularly important that can be done about reintegration prior to patient cryopreservation, which might be impossible, or at least far more difficult afterward. It also underestimates the impact that fear of dis-integration has on individuals’ decisions on whether to sign up for cryonics, which might be alleviated if we had more concrete plans for reintegration, with presently actionable components. In this talk, Keegan Macintosh will survey several aspects of cryonics patient reintegration, both legal and logistical, that can be tangibly worked on today.
Bio: Keegan Macintosh received his J.D. from the University of British Columbia in 2012, and is Executive Director of the Lifespan Society of British Columbia, a non-profit organization established to educate the public on life extension strategies and protect access to potentially life-saving technologies. Keegan is a board member of the Institute for Evidence Based Cryonics, as well as the Cryonics Society of Canada.
ASCHWIN DE WOLF – CRYONICS WITHOUT REPAIR
Cryonics aims to stabilize critically ill patients at low temperatures in anticipation of future medical treatment. While the concept of cell repair is often associated with the practice of cryonics, it is not an intrinsic element of the procedure. Advanced cryonics technologies will permit reversible cryopreservation of the patient. If human suspended animation would be achieved cryonics would solely involve future treatment of the patient’s disease and its underlying pathologies. In this talk I will discuss why reversible cryopreservation is important and which technical obstacles need to be overcome to make it a reality.
Bio: Aschwin is a Director and researcher for Advanced Neural Biosciences, the editor of Cryonics magazine, serves as a consultant for a number of cryonics organizations, and has published technical articles on various cryonics topics.
